Salahop, Judie C.
HRN: 16-69-61 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/02/2026
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
02/02/2026
03/09/2026
IV
500mg
Q8
Stab Wound
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominalProphylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes